Genomics Market Size, Share, Analysis, Trends, Growth, Forecasts, 2032

Genomics Market

Genomics Market - By Deliverables (Services And Products), By Application (Epigenomics, Functional, Biomarker Discovery, Pathway Analysis, And Others), And By End-User (Government And Academic Institutes, Clinical Research, Biotechnology And Pharmaceutical Companies, Hospitals And Clinics, And Others), By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024 – 2032

Category: Biotechnology Report Format : PDF Pages: 110 Report Code: ZMR-1080 Published Date: Mar-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 36.25 Billion USD 79.83 Billion 9.17% 2023

Genomics Industry Prospective:

The global genomics market size was worth around USD 36.25 Billion in 2023 and is predicted to grow to around USD 79.83 Billion by 2032 with a compound annual growth rate (CAGR) of roughly 9.17% between 2024 and 2032.

Global Genomics Market SizeRequest Free Sample

The report analyzes the global genomics market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the genomics industry. 

The report covers a forecast and an analysis of the genomics market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints of the bioinformatics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the genomics market on a global and regional level.

In order to give the users of this report a comprehensive view of the genomics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Genomics MarketRequest Free Sample

Genomics Market: Growth Drivers

There are a number of important variables that are driving the significant rise that the genomics market is seeing. In the first place, the area has been revolutionized by numerous developments in genomic technologies, such as next-generation sequencing (NGS) and CRISPR-Cas9 gene editing. These technologies have made it possible to analyze genetic information in a more expedient, accurate, and cost-effective manner. These technologies have broadened the breadth of genomic research and applications across a variety of industries, including the medical field, agriculture, and biotechnology, among others. A further factor that has contributed to the expansion of the market is the growing number of government programs and funding support for genetic research initiatives. These factors have also helped to develop collaboration between academic institutions, research organizations, and industry participants.

In addition, the increasing prevalence of genetic disorders and chronic diseases around the globe has led to an increase in the need for personalized medication and diagnostic solutions, which has further fueled the rise of the market. In addition, the growing knowledge among consumers regarding the advantages of genetic testing for illness prevention, diagnosis, and treatment customisation has prompted the adoption of genomic services, which has driven the expansion of the market. Within the context of the genomics market, the dynamic growth trajectory can be attributed to a number of factors, including the confluence of technological innovation, supporting regulatory frameworks, increased disease burden, and expanding consumer awareness.

Genomics Market: Report Scope

Report Attributes Report Details
Report Name Genomics Market Research Report
Market Size in 2023 USD 36.25 Billion
Market Forecast in 2032 USD 79.83 Billion
Growth Rate CAGR of 9.17%
Number of Pages 255
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Eurofins Scientific, Agilent Technologies, Inc., GE Healthcare, BGI, Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, and F. Hoffmann-La Roche Ltd., among others.
Segments Covered By Deliverables, By Application, By Displacement, By End-User, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Genomics Market: Segmentation

The market for genomics on a global scale has been segmented into three categories: deliverables, applications, and end users. Services and products are included in the genomics market structure, which is based on deliverables. Over the estimated time period, it is anticipated that the goods segment will hold the majority of the market share. This is primarily attributable to the frequent use of instruments and reagents for genomics research, as well as the growing number of research programs that are being carried out by both public and private organizations. There are several sub-segments that fall under the services category. These include NGS-based, core genomics, computational, biomarker translation, and others. Both reagents and instruments are considered to be sub-segments of the products. Epigenomics, functional analysis, biomarker discovery, and pathway analysis are some of the applications that are included in the application sector.

As a result of the enormous amount of sequencing data that was generated in 2018, functional division was the most dominant section of the application market. Chromatin immunoprecipitation (ChIP-Seq), bisulfite sequencing, methylation DNA immunoprecipitation (MeDIP), chromatin accessibility assays, high-resolution melt (HRM), and microarray analysis are the sub-segments that are included in the field of epigenomics. Real-time polymerase chain reaction (PCR), transfection, RNA interference, single nucleotide polymorphism (SNP) analysis, mutational analysis, and microarray analysis are the sub-categories that fall under the functional category.

Real-time polymerase chain reaction (PCR), mass spectrometry, microarray analysis, genomics, statistical analysis, and DNA sequencing are the sub-segments that make up the biomarker discovery process. Instruments for proteomics, microarray analysis, bead-based analysis, and real-time PCR are the sub-categories that fall under the umbrella of pathway analysis. The end-user category is comprised of a variety of entities, including but not limited to hospitals and clinics, clinical research facilities, biotechnology and pharmaceutical businesses, and government and academic institutions. Because of the growing number of people receiving training in genetic research, it is anticipated that biotechnology and pharmaceutical businesses would end up dominating the industry.

The report provides a company market share analysis to give a broader overview of the key players in the genomics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the genomics market on a global and regional basis.

Genomics Market: Competitive Analysis

Some key players in the global genomics market are 

  • Illumina. Inc.
  • Thermo Fisher Scientific. Inc.
  • QIAGEN N.V.
  • Eurofins Scientific
  • Agilent Technologies. Inc.
  • GE Healthcare
  • BGI
  • Bio-Rad Laboratories. Inc.
  • Oxford Nanopore Technologies
  • F. Hoffmann-La Roche Ltd.
  • And others

This report segments the global genomics market as follows:

Global Genomics Market: By Deliverables

  • Services
    • NGS-Based
    • Core Genomics
    • Computational
    • Biomarker Translation
    • Others
  • Products
    • Reagents
    • Instruments

Global Genomics Market: By Application

  • Epigenomics
    • Chromatin Immunoprecipitation (ChIP-Seq)
    • Bisulfite Sequencing
    • Methylated DNA Immunoprecipitation (MeDIP)
    • Chromatin Accessibility Assays
    • High-Resolution Melt (HRM)
    • Microarray Analysis
  • Functional
    • Real-Time PCR
    • Transfection
    • RNA Interference
    • SNP Analysis
    • Mutational Analysis
    • Microarray Analysis
  • Biomarker Discovery
    • Real-Time PCR
    • Mass Spectrometry
    • Microarray Analysis
    • Bioinformatics
    • Statistical Analysis
    • DNA Sequencing
  • Pathway Analysis
    • Microarray Analysis
    • Bead-Based Analysis
    • Real-Time PCR
    • Proteomics Tools
    • Others

Global Genomics Market: By End-User

  • Government and Academic Institutes
  • Clinical Research
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Clinics
  • Others

Global Genomics Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • the Middle East and Africa

Table Of Content

Methodology

FrequentlyAsked Questions

In molecular biology, genomics studies an organism's genome, or full DNA set. Structure, function, evolution, and mapping of genomes, including genes and non-coding regions, are examined. To study how genetics affects traits, behavior, and disease susceptibility, genomics uses DNA sequencing, gene expression profiling, and genome editing. This field provides insights into fundamental biological processes and helps develop new medicines, diagnostics, and genetically modified organisms in medicine, agriculture, evolutionary biology, and biotechnology.

According to the report, the global genomics market size was worth around USD 36.25 billion in 2023 and is predicted to grow to around USD 79.83 billion by 2032.

The global Running Shoes market is expected to grow at a CAGR of 9.17% during the forecast period.

North America has been leading the global Genomics  market and is anticipated to continue on the dominant position in the years to come.

Some key players of the global genomics market are Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Eurofins Scientific, Agilent Technologies, Inc., GE Healthcare, BGI, Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, and F. Hoffmann-La Roche Ltd.

The global Genomics market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed